Rare diseases
Investigational molecules
Locations
Study on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery
PolandStudy of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation
PolandStudy of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes
PolandStudy of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
PolandStudy Comparing Tirzepatide and Semaglutide for Weight Loss in Adults with Obesity or Overweight and Related Health Issues
PolandStudy on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer
PolandStudy for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab
PolandStudy of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy
PolandStudy on Metreleptin for Patients with Partial Lipodystrophy
PolandLong-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases
PolandStudy of Pembrolizumab for Patients with Advanced Solid Tumors
PolandStudy Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
